#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2898	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2395	289.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1644	1644	C	357	C,A,T	343,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2898	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2395	289.4	0	HET	.	.	.	C207T	.	207	207	C	667	667	C	282	C,T	218,51	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2898	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2395	289.4	0	HET	.	.	.	C451T	.	451	451	C	911	911	C	401	C,T	179,203	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5634	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	338.3	0	.	n	.	0	T695C	SNP	695	695	T	1322	1322	C	403	C,A,G	385,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5634	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	338.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2598	2598	C	415	C,T	400,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5634	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	338.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2672	2672	A	388	A	377	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5634	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	338.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3224	3224	C	434	C,A	426,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5634	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4145	338.3	0	HET	.	.	.	A1638G,C	.	1638	1638	A	2265	2265	A	403	A,G,C	211,180,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	504	folP	855	855	100.0	folP.l15.c4.ctg.1	2164	57.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1345	1347	AGC	72;73;71	A;G;C	69;73;70	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	822	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4133	49.3	1	SNP	p	S91F	1	.	.	271	273	TTC	928	930	TTC	58;59;59	T,C;T;C	54,1;53;55	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	822	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4133	49.3	1	SNP	p	G95N	0	.	.	283	285	GGC	940	942	GGC	58;58;58	G;G;C	55;56;54	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	822	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4133	49.3	1	SNP	p	D95G	1	.	.	283	285	GGC	940	942	GGC	58;58;58	G;G;C	55;56;54	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	822	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4133	49.3	0	HET	.	.	.	G2381A,C,T	.	2381	2381	G	3038	3038	G	62	G,A,C,T	42,8,3,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	464	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	2101	55.1	1	SNP	p	G45D	0	.	.	133	135	GGC	982	984	GGC	93;93;93	G;G;C	90;89;90	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	266	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1589	41.3	0	.	n	.	0	A197.	DEL	197	197	A	889	889	A	88	A	84	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	958	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3563	66.6	1	SNP	p	D86N	0	.	.	256	258	GAC	935	937	GAC	71;70;74	G;A,C;C	56;53,1;63	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	958	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3563	66.6	1	SNP	p	R87W	0	.	.	259	261	CGT	938	940	CGT	75;75;76	C;G;T	66;62;63	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	958	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3563	66.6	1	SNP	p	S87R	1	.	.	259	261	CGT	938	940	CGT	75;75;76	C;G;T	66;62;63	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	958	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3563	66.6	1	SNP	p	R87I	0	.	.	259	261	CGT	938	940	CGT	75;75;76	C;G;T	66;62;63	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	958	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3563	66.6	1	SNP	p	S88P	0	.	.	262	264	TCC	941	943	TCC	76;77;75	T,C;C;C	67,1;69;66	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	774	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3179	60.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1851	1853	GGC	55;55;56	G,A;G;C	49,1;50;46	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1514	1516	GCC	99;100;100	G;C;C	97;98;98	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1517	1519	ATG	100;101;101	A;T;G	98;99;99	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1529	1531	ACC	103;103;103	A;C;C	98;100;100	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1529	1531	ACC	103;103;103	A;C;C	98;100;100	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2030	2032	ACC	85;85;85	A;C,A;C	77;73,3;82	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2084	2086	GCG	83;82;82	G;C;G	71;64;68	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2084	2086	GCG	83;82;82	G;C;G	71;64;68	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2207	2209	GGT	65;65;62	G;G;T,G	63;63;60,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2216	2218	AGC	55;55;54	A;G;C	49;48;42	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	724	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2668	66.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2234	2236	CCG	47;46;47	C,G;C;G,C	40,1;38;43,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1088	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3643	74.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1936	1938	CCG	101;102;101	C,G;C;G,C	88,1;93;81,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	446	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2294	48.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	827	827	C	41	C	37	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	452	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2370	47.6	1	SNP	p	G120K	1	.	.	358	360	AAG	1047	1049	AAG	59;59;58	A,G;A;G	57,1;58;57	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	452	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2370	47.6	1	SNP	p	A121N	1	.	.	361	363	AAC	1050	1052	AAC	58;58;59	A;A;C	55;56;57	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	452	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2370	47.6	1	SNP	p	N121D	0	.	.	361	363	AAC	1050	1052	AAC	58;58;59	A;A;C	55;56;57	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1480	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5396	68.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	152	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1491	25.5	1	SNP	p	V57M	1	.	.	169	171	ATG	789	791	ATG	45;45;47	A;T;G	42;44;46	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
